Unique characteristics of the tumor immune microenvironment in young patients with metastatic colorectal cancer

Front Immunol. 2023 Dec 13:14:1289402. doi: 10.3389/fimmu.2023.1289402. eCollection 2023.

Abstract

Introduction: Metastatic colorectal cancer (mCRC) remains a common and highly morbid disease, with a recent increase in incidence in patients younger than 50 years. There is an acute need to better understand differences in tumor biology, molecular characteristics, and other age-related differences in the tumor microenvironment (TME).

Methods: 111 patients undergoing curative-intent resection of colorectal liver metastases were stratified by age into those <50 years or >65 years old, and tumors were subjected to multiplex fluorescent immunohistochemistry (mfIHC) to characterize immune infiltration and cellular engagement.

Results: There was no difference in infiltration or proportion of immune cells based upon age, but the younger cohort had a higher proportion of programmed death-ligand 1 (PD-L1)+ expressing antigen presenting cells (APCs) and demonstrated decreased intercellular distance and increased cellular engagement between tumor cells (TCs) and cytotoxic T lymphocytes (CTLs), and between TCs and APCs. These trends were independent of microsatellite instability in tumors.

Discussion: Age-related differences in PD-L1 expression and cellular engagement in the tumor microenvironment of patients with mCRC, findings which were unrelated to microsatellite status, suggest a more active immune microenvironment in younger patients that may offer an opportunity for therapeutic intervention with immune based therapy.

Keywords: colorectal cancer; immunotherapy; multiplex immunohistochemistry (IHC); spatial relation analysis; tumor immunology.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Aged
  • B7-H1 Antigen / metabolism
  • Colonic Neoplasms*
  • Colorectal Neoplasms*
  • Humans
  • Middle Aged
  • Rectal Neoplasms*
  • T-Lymphocytes, Cytotoxic
  • Tumor Microenvironment

Substances

  • B7-H1 Antigen